Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients

BACKGROUND: It is known that severe acute respiratory coronavirus 2 (SARS-CoV-2) is the viral strain responsible for the recent coronavirus disease 2019 (COVID-19) pandemic. Current documents have demonstrated that the virus causes a PGE2 storm in a substantial proportion of patients via upregulatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaznavi, Habib, Mohammadghasemipour, Zahra, Shirvaliloo, Milad, Momeni, Mohammad Kazem, Metanat, Malihe, Gorgani, Farzaneh, Abedipour, Fatemeh, Mohammadi, Mahdi, Sartipi, Majid, Khorashad, Ali Reza Salimi, Shahraki, Omolbanin, Ataee, Mohadese, Sheervalilou, Roghayeh, Sargazi, Saman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281238/
https://www.ncbi.nlm.nih.gov/pubmed/35834150
http://dx.doi.org/10.1007/s10787-022-01029-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281238/
https://www.ncbi.nlm.nih.gov/pubmed/35834150
http://dx.doi.org/10.1007/s10787-022-01029-4

Ejemplares similares